The latest Investing Matters Podcast episode featuring financial educator and author Jared Dillian has been released. Listen here.
London South East prides itself on its community spirit, and in order to keep the chat section problem free, we ask all members to follow these simple rules. In these rules, we refer to ourselves as "we", "us", "our". The user of the website is referred to as "you" and "your".
By posting on our share chat boards you are agreeing to the following:
The IP address of all posts is recorded to aid in enforcing these conditions. As a user you agree to any information you have entered being stored in a database. You agree that we have the right to remove, edit, move or close any topic or board at any time should we see fit. You agree that we have the right to remove any post without notice. You agree that we have the right to suspend your account without notice.
Please note some users may not behave properly and may post content that is misleading, untrue or offensive.
It is not possible for us to fully monitor all content all of the time but where we have actually received notice of any content that is potentially misleading, untrue, offensive, unlawful, infringes third party rights or is potentially in breach of these terms and conditions, then we will review such content, decide whether to remove it from this website and act accordingly.
Premium Members are members that have a premium subscription with London South East. You can subscribe here.
London South East does not endorse such members, and posts should not be construed as advice and represent the opinions of the authors, not those of London South East Ltd, or its affiliates.
Lol
Research paid for by Diurnal, so always one to take with a pinch of salt............but not unreasonable to think it will be twice this SP in the next 12 months
And there was me thinking...price 69.5p !! now that would be news lol
Sorry, my mistake!! Dated last month 3rd June!
Tomorrows news today! Additional research dated TOMORROW.
https://3955fac3-6193-423f-8049-efaec828a8db.filesusr.com/ugd/a182dd_8be7dec679a940d89505bdf002fa79fb.pdf
The MHRA's approval of Efmody this morning represents another important endorsement of the strength of the data supporting its efficacy and safety in patients with congenital adrenal hyperplasia (CAH). The availability of Efmody in the UK fleshes out the adrenal franchise. Efmody provides a hydrocortisone preparation that mimics its physiological release, thereby better-controlling complications of CAH, including overnight androgen build-up and the risk of life-threatening adrenal crises. Additionally, it should deliver operating leverage to the UK operations. As we have highlighted previously, we remain optimistic regarding the rollout of Efmody in Europe and the UK, given the already well-established commercial infrastructure and look forward to details of sales progression after launch.
The positive news follows the successful EU approval of Efmody in May and allows Diurnal access to a combined $250m market for Efmody.
Diurnal has a robust balance sheet and commercial opportunities of approximately $350m in Europe and the US for already approved products. This strong position allows the restart of Efmody’s US Phase 3 development. We believe that lessons learned from Efmody’s European Phase 3 study significantly improve the chances of US success. In addition, Efmody already has Orphan drug designation for both CAH and AI in the US, which provides extended exclusivity and a potentially enhanced market position.
We think that Diurnal’s current valuation overlooks the prospects for Efmody in Europe and the much larger adrenal insufficiency opportunity. In Europe alone, AI represents a $1.8bn market opportunity for Diurnal. With Efmody now approved for CAH in Europe, the regulatory pathway for AI appears uncomplicated, and Diurnal intends to conduct a comparator study with incumbent Plenadren for optimal market positioning. All going to plan, we would expect Efmody AI approval in Europe towards the end of 2023.
We calculate a DCF based fair value for Diurnal of 241p per share, which compares with a current share price of 69.5p.
Will keep adding as and when . I have never know a company to keep to the time frames like dnl . At least I can sleep at night . It was worth paying slightly more than yesterday as it’s in the bag for next year ! Funny old world we will get buyers at 1.25 next sept when we are running . I can wait load up if u can and don’t need money . Dnl is not a get rich quick share
Sorry muddled up meant we will start roll of in Europe third quarter 2021 .And we will sell in the uk by first quarter 2022
Nice I feel by middle of next year we will rerate as won’t sell in uk by 2022 first quarter etc start selling in Europe third quarter . All boxes getting ticked . Slow burner but will come together if this covid don’t go crazy again . A well run company . Seems we have a seller don’t know why patience needed here and be rewarded
Hey Hunsen. Hope you’re well. Yes my watchlist has hardly moved anywhere recently. I can’t help feeling here that it will just rapidly start moving upwards soon. There is so much value to be had here.
Hey Aim, I think the whole market has been quite flat since April / May, volumes in general are low and my PF is going nowhere fast, I was 21% up for the year in April, I'm now only 15% up year to date.
Considering the placing, I think DNL is doing ok, but sooner or later it needs to put in some gains. Loads of news to come.
ATB
It’s amazing We are still in the mid 60s - it surely can’t be long until we get back into the upward trend. I sound like a broken record
That would of been an NT trade and by a novice in my opinion. Please see 1 year chart to see where it’s going
im so disappointed i cant even spell "share " ...lol
it may be a "Great little company keeps delivering" but my nerves have been confirmed ,this share has no traction, sellers appearing already (10000 sells) this shear is a share to sell into any rise NOT buy into and move on... someone selling at 61.3566 as i speak tells all we need to know,such a shame....
Nearly cut losses and sold chunk of these yesterday. Let's hope more good news gets SP heading back upwards. Nice to have patience rewarded.
Good company and as you know Turkish good business people who try harder. Interesting times for sure
When all the pieces fall together and people cotton on about dnl we will rerate . Well done dnl ! Eastern Europe a good market and remember this is only the beginning . That’s why I keep loading up I will get my break very soon
Lots of news due. DNL are like fed ex. They always deliver. Eventually.
5081 that will do me now . 3 rd quarter soon hopefully on track for the launch gla . We must have a seller ! I bought a few lots and all put down as sells . Gla dnl so underloved
I agree. I am buying more in the morning
Will fund more tmw for a few thousand As imo 3 rd quarter will be interesting gla . I used all my share funds so will add more from bank gla
Out of share money now won’t fund it any more hopefully we will here commercialisation happening al over Europe and uk soon good luck all . I know I go on but I feel we should be over 80 p atm it will happen
Martin's next presentation update is 6th July AJ Bell webinar through Shares Mag.
GLA